Yahoo Web Search

Search results

1. • 

     Congress evaluate how to lower prescription prices by increasing competition

     WJAX via Yahoo News· 6 days ago

     David Mitchell has multiple myeloma which is a type of blood cancer without a cure. Tuesday, he told...

2. • 

     7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

     InvestorPlace via Yahoo Finance· 7 days ago

     Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...

3. • 

     Missouri residents affected by radiation exposure push Congress to extend benefits

     Louisiana Illuminator via Yahoo News· 2 days ago

     WASHINGTON — A fund to compensate Americans sickened by exposure to atomic bomb tests, uranium...

4. • 

     Congress evaluate how to lower prescription prices by increasing competition

     WFTV 9 Orlando· 6 days ago

     Roughly 30 percent of Americans say they’re struggling to pay for prescription drugs. “My doctors...

5. • 

     Mississippi author Greg Iles to host rare reading, book launch Tuesday in Jackson, Miss.

     St. Clair News-Aegis· 23 hours ago

     Beneath the heading “medical announcement,” Iles wrote a letter to his readers to let them know that...

6. • 

     Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline

     Zacks via Yahoo Finance· 4 days ago

     MorphoSys AG originally developed felzartamab for treating multiple myeloma. MorphoSys AG is due to...

7. • p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing...

     Nature· 6 days ago

     Cancer stem cells (CSCs), which are distinct subpopulations of tumor cells, have a substantially higher tumor-initiating capacity and are closely related to poor clinical outcomes. Damage to ...

8. • 

     ASCO24: An early look at cancer drug study results

     BioPharma Dive via Yahoo Finance· 4 days ago

     Clinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...

9. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 4 days ago

     Preliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such as non-small cell lung cancer (NSCLC) with oncogenic

10. • 

      Congress evaluate how to lower prescription prices by increasing competition

      WPXI· 6 days ago

      Roughly 30% of Americans say they’re struggling to pay for prescription drugs. “My doctors have me...